Price $54.33 |
Market Cap
12.2B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
64.1
|
P/B
4.46
|
P/S
7.06
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
68.2
|
Op. Cash Flow
297.5K
|
FCF
0.7
|
|
Op. Margin
18.10%
|
Net Margin
11.20%
|
ROE
7.40%
|
ROI
0.40%
|
|
ROA
3.60%
|
EPS Growth
851.00%
|
Current Ratio
1.7
|
Debt/Equity
56.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
| IRIDEX Corporation (IRIX) | $4.93 | - | - | 39.2M | Strong Buy |
| IntriCon Corporation (IIN) | $20.55 | - | - | 162.6M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.39 | - | - | 166.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
